Third Circuit Affirms Denial of Injunction in Janssen-Samsung Stelara Biosimilar Dispute
The Third Circuit on Friday upheld a district court's refusal to enjoin Samsung Bioepis from supplying a Cigna subsidiary with a private-label version of the ustekinumab biosimilar Pyzchiva, holding that Johnson &...